110 related articles for article (PubMed ID: 18816693)
1. Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin.
Lannuzel A; Ruberg M; Michel PP
Mov Disord; 2008 Nov; 23(15):2122-8. PubMed ID: 18816693
[TBL] [Abstract][Full Text] [Related]
2. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
3. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.
Champy P; Höglinger GU; Féger J; Gleye C; Hocquemiller R; Laurens A; Guérineau V; Laprévote O; Medja F; Lombès A; Michel PP; Lannuzel A; Hirsch EC; Ruberg M
J Neurochem; 2004 Jan; 88(1):63-9. PubMed ID: 14675150
[TBL] [Abstract][Full Text] [Related]
4. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
Caparros-Lefebvre D; Lees AJ
Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100
[TBL] [Abstract][Full Text] [Related]
5. Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe.
Champy P; Melot A; Guérineau Eng V; Gleye C; Fall D; Höglinger GU; Ruberg M; Lannuzel A; Laprévote O; Laurens A; Hocquemiller R
Mov Disord; 2005 Dec; 20(12):1629-33. PubMed ID: 16078200
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for a distinctive atypical degenerative parkinsonism in the Caribbean: A new cluster in the French West Indian Island of Martinique.
Lannuzel A; Edragas R; Lackmy A; Tressières B; Pelonde V; Kaptué MEN; Mécharles S; Demas A; François B; McGovern E; Vidailhet M; Gaymard B; Roze E
J Neurol Sci; 2018 May; 388():214-219. PubMed ID: 29525296
[TBL] [Abstract][Full Text] [Related]
7. Predominant cortical dysfunction in Guadeloupean parkinsonism.
Apartis E; Gaymard B; Verhaeghe S; Roze E; Vidailhet M; Lannuzel A
Brain; 2008 Oct; 131(Pt 10):2701-9. PubMed ID: 18941145
[TBL] [Abstract][Full Text] [Related]
8. Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?
Lannuzel A; Höglinger GU; Champy P; Michel PP; Hirsch EC; Ruberg M
J Neural Transm Suppl; 2006; (70):153-7. PubMed ID: 17017523
[TBL] [Abstract][Full Text] [Related]
9. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Caparros-Lefebvre D; Elbaz A
Lancet; 1999 Jul; 354(9175):281-6. PubMed ID: 10440304
[TBL] [Abstract][Full Text] [Related]
10. Complex I: inhibitors, inhibition and neurodegeneration.
Schapira AH
Exp Neurol; 2010 Aug; 224(2):331-5. PubMed ID: 20362572
[TBL] [Abstract][Full Text] [Related]
11. Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses.
Caparros-Lefebvre D; Steele J
Environ Toxicol Pharmacol; 2005 May; 19(3):407-13. PubMed ID: 21783505
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the environmental neurotoxin annonacin in Rat brain by UPLC-MS/MS.
Bonneau N; Schmitz-Afonso I; Brunelle A; Touboul D; Champy P
Toxicon; 2016 Aug; 118():129-33. PubMed ID: 27058514
[TBL] [Abstract][Full Text] [Related]
13. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism.
Lannuzel A; Mecharles S; Tressières B; Demoly A; Alhendi R; Hédreville-Tablon MA; Alecu C
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):216-23. PubMed ID: 25646866
[TBL] [Abstract][Full Text] [Related]
14. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies.
Höllerhage M; Matusch A; Champy P; Lombès A; Ruberg M; Oertel WH; Höglinger GU
Exp Neurol; 2009 Nov; 220(1):133-42. PubMed ID: 19682988
[TBL] [Abstract][Full Text] [Related]
15. Tucupentol, a novel mono-tetrahydrofuranic acetogenin from Annona montana, as a potent inhibitor of mitochondrial complex I.
Alvarez Colom O; Neske A; Chahboune N; Zafra-Polo MC; Bardón A
Chem Biodivers; 2009 Mar; 6(3):335-40. PubMed ID: 19319860
[TBL] [Abstract][Full Text] [Related]
16. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Steele JC; Caparros-Lefebvre D; Lees AJ; Sacks OW
Parkinsonism Relat Disord; 2002 Oct; 9(1):39-54. PubMed ID: 12217621
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.
Lannuzel A; Michel PP; Caparros-Lefebvre D; Abaul J; Hocquemiller R; Ruberg M
Mov Disord; 2002 Jan; 17(1):84-90. PubMed ID: 11835443
[TBL] [Abstract][Full Text] [Related]
18. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons.
Escobar-Khondiker M; Höllerhage M; Muriel MP; Champy P; Bach A; Depienne C; Respondek G; Yamada ES; Lannuzel A; Yagi T; Hirsch EC; Oertel WH; Jacob R; Michel PP; Ruberg M; Höglinger GU
J Neurosci; 2007 Jul; 27(29):7827-37. PubMed ID: 17634376
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.
Molina-Porcel L; Lladó A; Rey MJ; Molinuevo JL; Martinez-Lage M; Esteve FX; Ferrer I; Tolosa E; Blesa R
Arch Neurol; 2008 Feb; 65(2):272-5. PubMed ID: 18268200
[TBL] [Abstract][Full Text] [Related]
20. Food toxins and the Caribbean Parkinson plus types.
Caparros Lefebvre D
Rev Neurol (Paris); 2019 Dec; 175(10):641-643. PubMed ID: 31519303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
